ORIGONI, MASSIMO
 Distribuzione geografica
Continente #
AS - Asia 2.484
NA - Nord America 1.523
EU - Europa 1.260
SA - Sud America 761
AF - Africa 42
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 2
Totale 6.075
Nazione #
US - Stati Uniti d'America 1.457
SG - Singapore 1.111
CN - Cina 674
BR - Brasile 630
SE - Svezia 415
IT - Italia 320
HK - Hong Kong 315
VN - Vietnam 187
RU - Federazione Russa 125
DE - Germania 90
GB - Regno Unito 61
AR - Argentina 51
IN - India 48
FI - Finlandia 45
MX - Messico 31
NL - Olanda 31
EC - Ecuador 27
ID - Indonesia 27
ES - Italia 26
AT - Austria 25
CA - Canada 25
IE - Irlanda 24
PL - Polonia 24
ZA - Sudafrica 24
JP - Giappone 22
FR - Francia 19
PT - Portogallo 19
BD - Bangladesh 18
TR - Turchia 16
CO - Colombia 15
PY - Paraguay 15
IQ - Iraq 14
CL - Cile 9
PK - Pakistan 9
UA - Ucraina 7
AE - Emirati Arabi Uniti 6
IL - Israele 6
LT - Lituania 6
UZ - Uzbekistan 6
AL - Albania 5
MA - Marocco 5
EG - Egitto 4
PE - Perù 4
RO - Romania 4
SA - Arabia Saudita 4
VE - Venezuela 4
AU - Australia 3
AZ - Azerbaigian 3
BO - Bolivia 3
BY - Bielorussia 3
CR - Costa Rica 3
DZ - Algeria 3
IR - Iran 3
NP - Nepal 3
SK - Slovacchia (Repubblica Slovacca) 3
TN - Tunisia 3
CH - Svizzera 2
DO - Repubblica Dominicana 2
JO - Giordania 2
KZ - Kazakistan 2
PA - Panama 2
SY - Repubblica araba siriana 2
AM - Armenia 1
BB - Barbados 1
BE - Belgio 1
BG - Bulgaria 1
BW - Botswana 1
EU - Europa 1
GF - Guiana Francese 1
GR - Grecia 1
GY - Guiana 1
IS - Islanda 1
JM - Giamaica 1
KE - Kenya 1
KG - Kirghizistan 1
LV - Lettonia 1
NI - Nicaragua 1
PH - Filippine 1
QA - Qatar 1
SI - Slovenia 1
SN - Senegal 1
TW - Taiwan 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
YE - Yemen 1
Totale 6.075
Città #
Singapore 448
Hong Kong 314
Dallas 274
Ashburn 259
Shanghai 163
Hefei 145
Lawrence 135
Princeton 135
Beijing 133
Ho Chi Minh City 84
Milan 79
São Paulo 60
New York 57
Moscow 56
Los Angeles 47
Boardman 41
Hanoi 38
Helsinki 32
Rio de Janeiro 24
Dublin 23
Nuremberg 22
Tokyo 22
Santa Clara 20
Munich 19
Orem 18
Johannesburg 17
Pune 17
Rome 17
Warsaw 16
Bologna 15
Belo Horizonte 14
Chennai 14
Guangzhou 14
Porto 14
London 13
Atlanta 12
Brasília 12
Brooklyn 12
Denver 12
Boston 11
Chicago 11
Guayaquil 11
Manchester 11
Poplar 11
Montreal 10
Vienna 10
Ankara 9
Houston 9
Mexico City 9
Porto Alegre 9
Querétaro 9
Tianjin 9
Turku 9
Washington 9
Amsterdam 8
Campinas 8
Da Nang 8
Islington 8
Ribeirão Preto 8
Stockholm 8
Buenos Aires 7
Frankfurt am Main 7
Guarulhos 7
Hải Dương 7
Phoenix 7
San Jose 7
Sorocaba 7
Surabaya 7
Bergamo 6
Carpineto Romano 6
Catania 6
Contagem 6
Cortona 6
Haiphong 6
Juiz de Fora 6
Piracicaba 6
Salvador 6
Tashkent 6
The Dalles 6
Asunción 5
Cape Town 5
Curitiba 5
Dubai 5
Naples 5
Nova Iguaçu 5
Novara 5
Santo André 5
Seattle 5
Tirana 5
Turin 5
Bauru 4
Blumenau 4
Cesano Boscone 4
Charlotte 4
Ciudad del Este 4
Council Bluffs 4
Goiânia 4
Jiaxing 4
Lima 4
Lucknow 4
Totale 3.259
Nome #
5-Hydroxytyrosol inhibits HIV-1 replication in primary cells of the lower and upper female reproductive tract 99
Surgical approaches to in-utero spina bifida repair: a Systematic Review 90
The Peritoneal Neovagina after Davydov's Laparoscopic Procedure in Mayer-Rokitansky-Küster-Hauser Syndrome: Morphology and Ultrastructure Investigation of the New Epithelium 88
Hysterectomy for cervical intraepithelial neoplasia: A retrospective observational multi-institutional study 87
Cervical Cancer Prevention: New Frontiers of Diagnostic Strategies 86
[HPV vaccination: not only female adolescents and not only prophylactic. Review and position paper of the Italian HPV Study Group (IHSG)] 84
Papillomavirus umano (HPV) con associata Sindrome della Vestibolite Vulvare e papillomatosi vestibolare 80
Clinicopathologic analysis of 370 cases of vulvar intraepithelial neoplasia - Italian Study Group on vulvar disease 80
Citologia, colposcopia, istologia ed ibridazione molecolare nella diagnosi di infezione cervicale da HPV: studio comparativo 74
Caesarean section: a woman's right? 72
An alternative approach for the treatment of vaginal atrophy 72
A 12-week treatment with fractional CO2 laser for vulvovaginal atrophy: a pilot study 71
Antigens of HLA system in patients with vulvar lichen sclerosus 70
"Low-grade positivity" of HPV viral load after atypical squamous cells of undetermined significance (ASC-US) cytology identifies women at low-risk for cervical intraepithelial neoplasia grade 2 and 3 70
Cervical Human papillomavirus in transplanted Italian women: a long-term prospective follow-up study. 69
Vaccinations in patients with multiple sclerosis: A Delphi consensus statement 69
Candidate Microbicide 5-hydroxytyrosol (5-HT) Inhibits Productive R5 HIV-1 Infection of Human Cervical Tissue Explants (CTE). 68
Bombelli - Castiglioni Ginecologia e Ostetricia 68
Antigens of the HLA system in women with vulvar lichen sclerosus. Association with HLA-B21 67
Postmenopausal vulvovaginal atrophy (VVA) is positively improved by topical hyaluronic acid application. A prospective, observational study 67
Prognostic Significance of Neutrophil/Lymphocytes Ratio (NLR) in Predicting Recurrence of Cervical Dysplasia 67
Colposcopy Accuracy and Diagnostic Performance: A Quality Control and Quality Assurance Survey in Italian Tertiary-Level Teaching and Academic Institutions—The Italian Society of Colposcopy and Cervico-Vaginal Pathology (SICPCV) 66
HPV Opportunistic Vaccination: A Literature Review and a Single-Center Experience in Northern Italy through the COVID-19 Pandemic 65
CD4+ T cells against human papillomavirus-18 E7 in patients with high-grade cervical lesions associate with the absence of the virus in the cervix 64
TERAPIA DELLA SM CON FARMACI BIOLOGICI: la questione HPV 63
Immunogenicity and safety of a nine-valent human papillomavirus vaccine in women 27–45 years of age compared to women 16–26 years of age: An open-label phase 3 study 60
Long-Term Follow-Up Outcomes in Women with In Situ/Microinvasive Adenocarcinoma of the Uterine Cervix Undergoing Conservative Treatment—Cervical Adenocarcinoma Study Group Italian Society of Colposcopy and Cervico-Vaginal Pathology 59
Incidenza, indicazioni e orientamenti dell'isterectomia ostetrica 58
An oral component: vaginal lesions were associated with gingival symptoms 58
Acute isolated tubal torsion in pregnancy due to twisted Morgagni hydatid 57
Results from an Italian consensus conference on prevention and management of infections in MS patients treated with biological and non biological disease modifying drugs 56
Low-Malignant Schwannoma of the Cervix in Pregnancy: A Case Report and Literature Systematic Review 55
Progetto SOPHY: Studio osservazionale sul pH vaginale e sullo stile di vita della donna nelle diverse età e condizioni fisiopatologiche. Parte I 54
Prognostic value of pathological patterns of lymph node positivity in squamous cell carcinoma of the vulva Stage III and IVA FIGO 53
Cervical Intraepithelial Neoplasia (CIN) in pregnancy: the state of the art 51
La sindrome ab ingestis in corso di taglio cesareo: incidenza e condotta terapeutica 51
Results from an italian Consensus Conference on prevention and management of infections in multiple sclerosis patients treated with biological and non biological disease modifying drugs 51
An unusual diagnosis of primary Non-Hodgkin lymphoma of the vagina stage IE 50
Botulinum toxin injection in vulva and vagina. Evidence from a literature systematic review 49
Micropapillomatosi del vestibolo vulvare e HPV: indagine biomolecolare su prelievo citologico: risultati preliminari 48
Il prurito vulvare non va sottovalutato 47
La diagnostica strumentale e di laboratorio in oncologia ginecologica 47
Splenic hamartoma in pregnancy 44
Spontaneous post-cesarean regression of massive cervico-vaginal condylomatosis in pregnancy 44
Prognostic value of pathological patterns of lymphnode positivity in squamous cell carcinoma of the vulva stage III and IVA FIGO 44
Topical testosterone in the treatment of vulvar lichen sclerosus 44
Extralesional detection and load of human papillomavirus DNA: a possible marker of preclinical tumor spread in cervical cancer 43
Fractional CO2 laser improves sexual function in women with vulvovaginal atrophy 43
Sexual function after fractional microablative CO2 laser in women with vulvovaginal atrophy 43
I nuovi biomarcatori: p16INK4a e Ki-67 (CINtec PLUS) 43
SOPHY project: an observational study of vaginal PH, lifestyle and correct intimate hygiene in women of different physiopathological conditions. Part II 42
Melanoma of the vulva: A pathologic study of 8 cases 42
High frequency of normal karyotypes in endometrial adenocarcinomas 42
I fattori di rischio per il tumore invasivo della vulva 42
In Situ/Microinvasive Adenocarcinoma of the Uterine Cervix and HPV-Type Impact: Pathologic Features, Treatment Options, and Follow-Up Outcomes—Cervical Adenocarcinoma Study Group (CAS-Group) 41
Topical oxatomide: An alternative approach for the treatment of vulvar lichen sclerosus 41
Efficacy of topical oxatomide in women with pruritus vulvae 41
Topical testosterone in the treatment of vulvar lichen sclerosus 41
Spinocellular carcinoma of the vulva. Critical review of the surgical case histories from 1967-1989 40
Topical testosterone in the treatment of vulvar Lichen Sclerosus 40
Sebaceous glands in the uterine portio. A report of two cases 40
HPV-DNA testing for cervical cancer precursors: from evidence to clinical practice 40
Extending Human Papillomavirus (HPV) vaccination beyond female adolescents and after treatment for high grade CIN: the Italian HPV Study Group (IHSG) review and position paper 40
TOPICAL TESTOSTERONE IN THE TREATMENT OF VULVAR LICHEN-SCLEROSUS 39
NEURAL BLOCKADE UNDER NEUROPHYSIOLOGICAL GUIDANCE FOR CHRONIC PELVIC PAIN IN 110 WOMEN AFFECTED BY PUDENDAL NEURALGIA (PN) 39
Spontaneous regression of low-grade cervical intraepithelial lesions is positively improved by topical bovine colostrum preparations (GINEDIE®). A multicentre, observational, italian pilot study 39
E6/E7 mRNA testing for human papilloma virus-induced high-grade cervical intraepithelial disease (CIN2/CIN3): A promising perspective 39
Gynecologic and Obstetric Surgery 39
Worsening immunodeficiency correlates with increasing frequency of HPV-correlated cervical intraepithelial lesions in HIV-infected women 39
Lichen sclerosus of the vulva 38
The coexistence of HPV16 and 18 related high grade intraepithelial neoplasia and microinvasive endocervical adenocarcinoma 38
Valuable expression of MIB1 index in serous ovarian tumors 37
Therapy of vulvar lichen sclerosus: testosterone vs. placebo. A randomized study 37
Elementi di chirurgia ginecologica benigna 37
Preneoplastic lesions of the vulva 37
Test HPV e prevenzione della carcinoma della cervice uterina - Dalle evidenze alla clinica. Guida Pratica 2010 37
The risk of infection in patients with multiple sclerosis treated with disease-modifying therapies: A Delphi consensus statement 37
Human papillomavirus DNA and pap tests: The need for cotesting in opportunistic setting during the transition time 36
Monitoring the activities of Italian colposcopy clinics before and during the COVID-19 pandemic 35
Human papillomavirus with co-existing vulvar vestibulitis syndrome and vestibular papillomatosis 35
Small Cell Carcinoma of the Ovary: Report of Three Cases of a Poor Prognosis Disease 35
Performance of HPV DNA testing in the follow-up after treatment of high-grade cervical lesions, adenocarcinoma in situ (AIS) and microinvasive carcinoma 35
Evaluation of the detection of human papillomavirus genotypes in cervical specimens by hybrid capture as screening for precancerous lesions in HIV-positive women 35
Microablative fractional CO2 laser improves dyspareunia related to vulvovaginal atrophy: A pilot study 35
Studio di progressione della Low Grade SIL in relazione alla tipizzazione virale dell'HPV: Risultati preliminari 35
DETERMINANTS OF INVASIVE VULVAR CANCER RISK - AN ITALIAN CASE-CONTROL STUDY 35
Protein S100 and cytokeratins A,B,C in vulvar lichen sclerosus: immunohistochemical study 34
Goserelin depot therapy for heavy dysfunctional uterine bleeding in severely anemic women 34
Serous borderline-malignancy tumors of the ovary 34
HPV-DNA test: indicazioni e strategie di utilizzo. in: APOG Aggiornamento Permanente in Ostetricia e Ginecologia 34
Gestione della paziente con pap test anormale. Linee Guida SICPCV 2006 34
The Prognostic Value of DNA Ploidy Determination in Endometrial Cancer 33
Esiti riproduttivi dopo chirurgia conservativa ovarica per neoplasie "borderline malignancy" 33
HPV-Testing in follow-up of patients treated for CIN2+ lesions 33
Vulvar dystrophies: diagnostic problems and therapeutic indications 33
Lesioni squamose intraepiteliali della cervice uterina (SIL): tipizzazione e significato prognostico dei genotipi di HPV 33
Human papillomavirus viral load expressed as relative light units (RLU)correlates with the presence and grade of preneoplastic lesions of the uterine cervix in atypical squamous cells of undetermined significance (ASCUS)cytology 33
Neurobiological mechanisms of pelvic pain 33
Prognostic significance of immunohistochemical phenotypes in patients treated for high-grade cervical intraepithelial neoplasia. 32
VIN usual type - From the past to the future 32
Totale 4.953
Categoria #
all - tutte 51.166
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 51.166


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022138 0 0 0 46 8 16 12 12 9 11 14 10
2022/2023762 313 172 41 2 3 89 33 50 33 7 5 14
2023/2024412 16 45 44 89 17 55 22 26 6 12 23 57
2024/20251.809 228 21 30 72 58 134 289 155 339 158 166 159
2025/20262.987 457 545 404 949 457 175 0 0 0 0 0 0
Totale 6.136